138 related articles for article (PubMed ID: 30641210)
1. Interleukin (IL)-8 polymorphisms and risk of prostate disorders.
Taheri M; Noroozi R; Dehghan A; Roozbahani GA; Omrani MD; Ghafouri-Fard S
Gene; 2019 Apr; 692():22-25. PubMed ID: 30641210
[TBL] [Abstract][Full Text] [Related]
2. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
Zambra FM; Biolchi V; Brum IS; Chies JA
Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
[TBL] [Abstract][Full Text] [Related]
3. An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian Population.
Dargahi Abbasabad G; Banan Khojasteh SM; Eskandari Naji H; Zamani MR; Hajipour H; Serati-Nouri H
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1717-1720. PubMed ID: 29938471
[TBL] [Abstract][Full Text] [Related]
4. Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer risk.
Zambra FM; Biolchi V; de Cerqueira CC; Brum IS; Castelli EC; Chies JA
HLA; 2016 Feb; 87(2):79-88. PubMed ID: 26889902
[TBL] [Abstract][Full Text] [Related]
5. Interleukin (IL)-8 polymorphisms contribute in suicide behavior.
Noroozi R; Omrani MD; Ayatollahi SA; Sayad A; Ata A; Fallah H; Taheri M; Ghafouri-Fard S
Cytokine; 2018 Nov; 111():28-32. PubMed ID: 30099207
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
Gunes S; Bagci H; Sarikaya S; Bilen CY; Kara N
DNA Cell Biol; 2007 Dec; 26(12):873-8. PubMed ID: 17961073
[TBL] [Abstract][Full Text] [Related]
7. SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
Winchester D; Ricks-Santi L; Mason T; Abbas M; Copeland RL; Beyene D; Jingwi EY; Dunston GM; Kanaan YM
Anticancer Res; 2015 Jul; 35(7):3811-9. PubMed ID: 26124326
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
Li Z; Habuchi T; Tsuchiya N; Mitsumori K; Wang L; Ohyama C; Sato K; Kamoto T; Ogawa O; Kato T
Carcinogenesis; 2004 Feb; 25(2):237-40. PubMed ID: 14604900
[TBL] [Abstract][Full Text] [Related]
9. IL-6 Genomic Variants and Risk of Prostate Cancer.
Taheri M; Noroozi R; Rakhshan A; Ghanbari M; Omrani MD; Ghafouri-Fard S
Urol J; 2019 Oct; 16(5):463-468. PubMed ID: 30345492
[TBL] [Abstract][Full Text] [Related]
10. Common variants at 8q24 are associated with prostate cancer risk in Serbian population.
Branković AS; Brajušković GN; Mirčetić JD; Nikolić ZZ; Kalaba PB; Vukotić VD; Tomović SM; Cerović SJ; Radojičić ZA; Savić-Pavićević DL; Romac SP
Pathol Oncol Res; 2013 Jul; 19(3):559-69. PubMed ID: 23532531
[TBL] [Abstract][Full Text] [Related]
11. Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer.
Adabi Z; Mohsen Ziaei SA; Imani M; Samzadeh M; Narouie B; Jamaldini SH; Afshari M; Safavi M; Roshandel MR; Hasanzad M
Arch Med Res; 2015 Oct; 46(7):546-50. PubMed ID: 26319608
[TBL] [Abstract][Full Text] [Related]
12. Association of IL-1β and IL-10 Polymorphisms with Prostate Cancer Risk and Grade of Disease in Eastern Croatian Population.
Horvat V; Mandić S; Marczi S; Mrčela M; Galić J
Coll Antropol; 2015 Jun; 39(2):393-400. PubMed ID: 26753456
[TBL] [Abstract][Full Text] [Related]
13. Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis.
Nikolić ZZ; Branković AS; Savić-Pavićević DL; Preković SM; Vukotić VD; Cerović SJ; Filipović NN; Tomović SM; Romac SP; Brajušković GN
Clin Transl Sci; 2014 Aug; 7(4):307-13. PubMed ID: 24422606
[TBL] [Abstract][Full Text] [Related]
14. Association of codon 10 polymorphism of the transforming growth factor beta 1 gene with prostate cancer and hyperplasia in an Iranian population.
Omrani MD; Taghipour-Bazargani S; Salari-Lak S; Bagheri M
Urol Int; 2009; 83(3):329-32. PubMed ID: 19829035
[TBL] [Abstract][Full Text] [Related]
15. HOTAIR genetic variants are associated with prostate cancer and benign prostate hyperplasia in an Iranian population.
Taheri M; Habibi M; Noroozi R; Rakhshan A; Sarrafzadeh S; Sayad A; Omrani MD; Ghafouri-Fard S
Gene; 2017 May; 613():20-24. PubMed ID: 28259691
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.
Habuchi T; Liqing Z; Suzuki T; Sasaki R; Tsuchiya N; Tachiki H; Shimoda N; Satoh S; Sato K; Kakehi Y; Kamoto T; Ogawa O; Kato T
Cancer Res; 2000 Oct; 60(20):5710-3. PubMed ID: 11059764
[TBL] [Abstract][Full Text] [Related]
17. Association study of Retinoic Acid Related Orphan Receptor A (RORA) gene and risk of prostate disorders.
Taheri M; Noroozi R; Dehghan A; Atri Roozbahani G; Musavi M; Omrani MD; Ghafouri-Fard S
Urol J; 2019 May; 16(2):141-144. PubMed ID: 30251751
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism.
Wang L; Habuchi T; Mitsumori K; Li Z; Kamoto T; Kinoshita H; Tsuchiya N; Sato K; Ohyama C; Nakamura A; Ogawa O; Kato T
Int J Cancer; 2003 Jan; 103(1):116-20. PubMed ID: 12455063
[TBL] [Abstract][Full Text] [Related]
19. Association of G/A polymorphism, rs266882, in AREI region of the prostate-specific antigen gene with prostate cancer risk and clinicopathological features.
Samzadeh M; Hasanzad M; Jamaldini SH; Haghdoost AA; Afshari M; Ziaee SA
Urol J; 2012; 9(4):691-9. PubMed ID: 23235975
[TBL] [Abstract][Full Text] [Related]
20. Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.
Takahashi H; Lu W; Watanabe M; Katoh T; Furusato M; Tsukino H; Nakao H; Sudo A; Suzuki H; Akakura K; Ikemoto I; Asano K; Ito T; Wakui S; Muto T; Hano H
Int J Cancer; 2003 Nov; 107(2):224-8. PubMed ID: 12949798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
